comparemela.com

Latest Breaking News On - Murchinson ltd - Page 1 : comparemela.com

Super League Enterprise, Inc. (NASDAQ:SLE) Short Interest Down 62.6% in May

Super League Enterprise, Inc. (NASDAQ:SLE – Get Free Report) was the target of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 52,400 shares, a decline of 62.6% from the May 15th total of 140,100 shares. Based on an average daily trading volume, of […]

Securities-exchange-commission
News-ratings-for-super-league-enterprise-daily
Nasdaq
Murchinson-ltd
Super-league-enterprise-inc
Super-league-enterprise-price-performance
Super-league-enterprise
Get-free-report
Free-report
League-enterprise
Super-league-enterprise-daily

Guardforce AI (NASDAQ:GFAI) Trading Up 1.9%

Guardforce AI Co., Limited (NASDAQ:GFAI – Get Free Report) shares rose 1.9% on Wednesday . The company traded as high as $2.68 and last traded at $2.64. Approximately 75,676 shares changed hands during trading, a decline of 77% from the average daily volume of 330,680 shares. The stock had previously closed at $2.59. Guardforce AI […]

Thailand
Guardforce-ai-co
Exchange-commission
Security-solutions
Murchinson-ltd
Nasdaq
Get-free-report
Free-report
Secured-logistics-business
General-security-solutions
Robotics-solution-business

Spero Therapeutics (NASDAQ:SPRO) Stock Crosses Below Two Hundred Day Moving Average of $1.50

Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.50 and traded as low as $1.41. Spero Therapeutics shares last traded at $1.45, with a volume of 113,012 shares traded. Analyst Ratings Changes Several equities […]

United-states
Cantor-fitzgerald
Spero-therapeutics-inc
Murchinson-ltd
Virtu-financial
Vanguard-group-inc
Capital-management
Acadian-asset-management
Nasdaq
Spero-therapeutics
Get-free-report

Cytokinetics, Incorporated (NASDAQ:CYTK) Director Robert Arthur Harrington Sells 1,580 Shares

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 1,580 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $48.64, for a total transaction of $76,851.20. Following the sale, the director now directly owns 15,541 shares in the company, valued […]

United-states
America
Robert-arthur-harrington
Raymond-james
Cetera-advisors
Murchinson-ltd
Cytokinetics-company-profile
Securities-exchange-commission
Castleark-management
Comerica-bank
Cytokinetics-incorporated
Get-free-report

Cytokinetics, Incorporated (NASDAQ:CYTK) Director Sells $76,851.20 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 1,580 shares of the company’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $48.64, for a total value of $76,851.20. Following the transaction, the director now directly owns 15,541 shares in the company, valued […]

Raymond-james
Robert-arthur-harrington
Cetera-advisors
Murchinson-ltd
Securities-exchange-commission
Castleark-management
Comerica-bank
Barclays
Nasdaq
Cytokinetics-incorporated
Get-free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.